Fortress Biotech Inc FBIO Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Nov 14, 2023 (filed on Nov 16, 2023)

Insider Name:

Rosenwald Lindsay A Md

Ownership Type:

Direct Ownership

Securities:

Warrants to purchase Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,567,515

Price:

--
Nov 14, 2023 (filed on Nov 16, 2023)

Insider Name:

Rosenwald Lindsay A Md

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK, PAR VALUE $0.001

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,567,515

Price:

$1.70
Nov 14, 2023 (filed on Nov 16, 2023)

Insider Name:

Weiss Michael S

Ownership Type:

Direct Ownership

Securities:

Warrants to purchase Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

147,058

Price:

--
Nov 14, 2023 (filed on Nov 16, 2023)

Insider Name:

Weiss Michael S

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK, PAR VALUE $0.001

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

147,058

Price:

$1.70
Sep 26, 2023 (filed on Sep 27, 2023)

Insider Name:

Rosenwald Lindsay A Md

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK, PAR VALUE $0.001

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

100,000

Price:

$0.28
Aug 18, 2023 (filed on Aug 21, 2023)

Insider Name:

Rosenwald Lindsay A Md

Ownership Type:

Direct Ownership

Securities:

SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

10,000

Price:

$9.34
Aug 17, 2023 (filed on Aug 21, 2023)

Insider Name:

Rosenwald Lindsay A Md

Ownership Type:

Direct Ownership

Securities:

SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

10,000

Price:

$11.75
Feb 10, 2023 (filed on Feb 14, 2023)

Insider Name:

Weiss Michael S

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK, PAR VALUE $0.001

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,197,604

Price:

$0.84
Feb 10, 2023 (filed on Feb 14, 2023)

Insider Name:

Rowinsky Eric K

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK, PAR VALUE $0.001

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

11,976

Price:

$0.84
Feb 10, 2023 (filed on Feb 14, 2023)

Insider Name:

Rosenwald Lindsay A Md

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK, PAR VALUE $0.001

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

2,395,209

Price:

$0.84

Filings by filing date

Nov 14, 2023 (filed on Nov 16, 2023)

Insider Name:

Rosenwald Lindsay A Md

Ownership Type:

Direct Ownership

Securities:

Warrants to purchase Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,567,515

Price:

--
Nov 14, 2023 (filed on Nov 16, 2023)

Insider Name:

Rosenwald Lindsay A Md

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK, PAR VALUE $0.001

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,567,515

Price:

$1.70
Nov 14, 2023 (filed on Nov 16, 2023)

Insider Name:

Weiss Michael S

Ownership Type:

Direct Ownership

Securities:

Warrants to purchase Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

147,058

Price:

--
Nov 14, 2023 (filed on Nov 16, 2023)

Insider Name:

Weiss Michael S

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK, PAR VALUE $0.001

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

147,058

Price:

$1.70
Sep 26, 2023 (filed on Sep 27, 2023)

Insider Name:

Rosenwald Lindsay A Md

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK, PAR VALUE $0.001

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

100,000

Price:

$0.28
Aug 18, 2023 (filed on Aug 21, 2023)

Insider Name:

Rosenwald Lindsay A Md

Ownership Type:

Direct Ownership

Securities:

SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

10,000

Price:

$9.34
Aug 17, 2023 (filed on Aug 21, 2023)

Insider Name:

Rosenwald Lindsay A Md

Ownership Type:

Direct Ownership

Securities:

SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

10,000

Price:

$11.75
Feb 10, 2023 (filed on Feb 14, 2023)

Insider Name:

Weiss Michael S

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK, PAR VALUE $0.001

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,197,604

Price:

$0.84
Feb 10, 2023 (filed on Feb 14, 2023)

Insider Name:

Rowinsky Eric K

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK, PAR VALUE $0.001

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

11,976

Price:

$0.84
Feb 10, 2023 (filed on Feb 14, 2023)

Insider Name:

Rosenwald Lindsay A Md

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK, PAR VALUE $0.001

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

2,395,209

Price:

$0.84

News

Biz Brief

Sector: Healthcare	Industry: Pharmaceuticals

See Regulatory Filings on SEC

Company Contact

Address:	1111 KANE CONCOURSE, SUITE 301 BAY HARBOR ISLANDS FL 33154
Tel:	1-781-6524500
Website:	https://www.fortressbiotech.com
IR:	See website

Key People

Lindsay A. Rosenwald Executive Chairman of the Board, President, Chief Executive Officer	Eric K. Rowinsky Co-Vice Chairman of the Board	David Jin Chief Financial Officer, Corporate Secretary
Michael S. Weiss Executive Vice Chairman - Strategic Development, Director	George C. Avgerinos Senior Vice President - Biologics Operations

Business Overview

Fortress Biotech, Inc. is a biopharmaceutical company that acquires, develops and commercializes pharmaceutical and biotechnology products and product candidates. The Company markets its various branded dermatology products, Qbrexza, Accutane, Amzeeq, Zilxi, Ximino, Exelderm and Targadox. Qbrexza (glycopyrronium 2.4%) is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis in adults and children nine years and older. Accutane (isotretinoin) is an oral capsule for the treatment of severe recalcitrant nodular acne. Amzeeq (minocycline 4%) topical foam is a topical minocycline treatment for the inflammatory lesions of non-nodular moderate to severe acne vulgaris in adults and children nine years and older. Zilxi (minocycline 1.5%) is a topical foam and a topical minocycline treatment for inflammatory lesions of rosacea in adults. Ximino (minocycline hydrochloride) is an oral minocycline drug for the treatment of moderate to severe acne.

Financial Overview

For the nine months ended 30 September 2023, Fortress Biotech Inc revenues increased 9% to $64.6M. Net loss applicable to common stockholders decreased 13% to $57.4M. Revenues reflect Dermatology Product segment increase of 11% to $63.9M. Lower net loss reflects General and administarative decrease of 15% to $60.5M (expense), Research and developement decrease of 11% to $85.3M (expense).

Employees:	187 as of Dec 31, 2022

Reporting Currency:	U.S. Dollars
Enterprise value:	$25.42M as of Sep 30, 2023
Annual revenue (TTM):	$80.97M as of Sep 30, 2023
EBITDA (TTM):	-$167.18M as of Sep 30, 2023
Net annual income (TTM):	-$84.33M as of Sep 30, 2023
Free cash flow (TTM):	-$150.03M as of Sep 30, 2023
Net Debt Last Fiscal Year:	N/A
Shares outstanding:	14,827,751 as of Nov 10, 2023
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization